Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

18. Juli 2019 16:30 ET | Quelle: Glacier Bancorp, Inc.

Glacier Bancorp, Inc. Announces Results for the Quarter Ended June 30, 2019

2nd Quarter 2019 Highlights: Net income of $52.4 million for the current quarter, an increase of $8.0 million, or 18 percent, over the prior year second quarter net income of $44.4 million.Current...
11. Juli 2019 17:30 ET | Quelle: Delphi Energy Corporation

Delphi Energy Corp. Announces Extension of Credit Facility

CALGARY, Alberta, July 11, 2019 (GLOBE NEWSWIRE) -- Delphi Energy Corp. (“Delphi” or the “Company”) announces that the annual borrowing base redetermination of its senior credit facility has been...
01. Juli 2019 08:00 ET | Quelle: Catalyst Biosciences, Inc.

Catalyst Biosciences Announces Oral and Poster Presentations at the International Society on Thrombosis and Haemostasis

Oral presentation of the final Phase 2 trial data of MarzAA for the treatment of hemophilia A or B with inhibitors Company to host investor call and webcast on Monday, July 8 at 8:00 a.m. EDT SOUTH...
10. Juni 2019 14:58 ET | Quelle: Isodiol

Isodiol International Inc. Announces 2018 AGM Voting Results; Provides Update on Partnership with the Asian American Trade Associations Council (AATAC)

VANCOUVER, British Columbia, June 10, 2019 (GLOBE NEWSWIRE) -- Isodiol International Inc. (CSE: ISOL) (OTCQB:ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”), today announces the voting results...
10. Juni 2019 09:00 ET | Quelle: CohBar, Inc.

CohBar poster available on preclinical results showing efficacy of a new family of mitochondria based therapeutics in a type 2 diabetes model as presented at the American Diabetes Association 79th Scientific Sessions

MENLO PARK, Calif., June 10, 2019 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company focused on developing mitochondria based therapeutics to treat age-related...
10. Juni 2019 08:05 ET | Quelle: Diasome Pharmaceuticals, Inc.

Diasome’s Hepatocyte Directed Vesicle (HDV) Technology Met Primary Endpoint in Phase 2b Trial in Type 1 Diabetes

Hepatic safety also confirmed over six months of treatment with mealtime liver targeted insulin Company focused on Phase 3 initiation in 2020 CLEVELAND, June 10, 2019 (GLOBE NEWSWIRE) -- Diasome...
09. Juni 2019 14:00 ET | Quelle: MannKind

MannKind Presents Positive Afrezza® Clinical Data from Three Studies at ADA 79th Scientific Sessions

WESTLAKE VILLAGE, Calif., June 09, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) announced that new data from three different studies of Afrezza® (insulin human) Inhalation Powder...
08. Juni 2019 13:00 ET | Quelle: Medtronic plc

Medtronic Initiates Pivotal Trial for Bluetooth Enabled MiniMed(TM) 780G Advanced Hybrid Closed Loop System Designed to Automate Correction Bolusing

DUBLIN - June 8, 2019 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the enrollment of the first study participants in the company's pivotal trial of its...
08. Juni 2019 11:46 ET | Quelle: Novo Nordisk A/S

Oral semaglutide showed superior reductions in blood sugar vs Jardiance® and non-inferior blood sugar reductions vs Victoza® in adults with type 2 diabetes at 26 weeks

Secondary data at 52 weeks demonstrated statistically significant blood sugar reductions and statistically significant reduction of body weight vs both Jardiance® and Victoza® San Francisco, US, 8...
07. Juni 2019 10:55 ET | Quelle: Amarin Corporation plc

CORRECTING and REPLACING -- Amarin to Present Findings Regarding Challenges of Current Treatment Options in Reducing Cardiovascular Risks for Diabetes Patients, Even for Those With Controlled Cholesterol Levels, at Annual American Diabetes Association (ADA) Meeting

Approximately 10 Million People with Diabetes Are at Elevated Risk of Cardiovascular Disease1,2 In a release issued under the same headline earlier today by Amarin Corporation plc (NASDAQ: AMRN),...

Vorherige Seite

Nächste Seite